Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: PNC stock price vs ALNY: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ALNY's multiple
Needs ALNY P/E.
Implied fair value · at PNC's multiple
Needs PNC P/E.
Live quote
Price unavailable
Metric by metric
Filter, sort, and scan the equity metrics that matter most for banks: book value, tangible book, returns, and operating efficiency.
Lower is better
Lower is better
Profitability lag
Asset efficiency lag
Lower is better
Statements
Bank-focused income statement and equity metrics aligned to the reporting windows.
SEC periods: PNC FY 2025 (ended Dec 31, 2025) · ALNY FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Tangible book and profitability anchor a bank, not enterprise value.
Deposits and cash-like balances distort enterprise value for banks, so this section reads equity value, tangible book and profitability instead.
Price / book
Market cap
—
Tangible equity
$49.25B
Price / tangible book
—
Price / book
—
Return on equity
11.5%
Return on assets
1.2%
Efficiency ratio
58.6%
Price / book
Market cap
—
Tangible equity
$788.90M
Price / tangible book
—
Price / book
—
Return on equity
39.8%
Return on assets
6.3%
Efficiency ratio
—
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
PNC Financial Services Group, Inc. · implied price per share
Bank model off — standard DCF modelling is disabled for financial institutions.
ALNYLAM PHARMACEUTICALS, INC. · implied price per share
Bear
$24.50
Base
$28.82
Bull
$33.15
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
1.20x
3.75x
Net debt / EBITDA
Leverage against operating earnings
-1.15x
1.82x
Cash and equivalents
Liquid reserves on the balance sheet
$108.67B
$1.66B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider banking comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
JPMorgan Chase & Co.
PNC vs JPM
Bank of America Corporation
PNC vs BAC
Citigroup Inc.
PNC vs C
Wells Fargo & Company
PNC vs WFC
Moderna, Inc.
PNC vs MRNA
Sarepta Therapeutics, Inc.
PNC vs SRPT
VERTEX PHARMACEUTICALS INC / MA
PNC vs VRTX
BioNTech SE
PNC vs BNTX
ACADIA PHARMACEUTICALS INC
PNC vs ACAD
$72.74B
$2.96B
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
